business EUROPEAN 16 Interview with Eric Rougemond, Chief Executive Officer of Laboratoire AGUETTANT SAS Drug delivery made easy An effective, medication-based treatment of diseases generally depends on two things: the right drug and the right delivery system. Rarely are these two fundamental prerequisites provided from a single source. An exception is Laboratoire AGUETTANT SAS. The privately owned French pharmaceutical company not only delivers highly effective, injectable drugs but also easy-to-use delivery systems which make administering the drugs efficient, convenient and perfectly safe. Laboratoire AGUETTANT is an independent, medium-sized family enterprise which specializes in injectable medicines. The pioneering pharmaceutical company has been focusing on injectable solutions since 1903 and was founded as a distributor of chemical and pharmaceutical products by Louis- Joseph Aguettant and Bruno Tavernier in 1880. Today, Laboratoire AGUETTANT operates globally with over 500 employees, annual revenues of 110 million EUR, two modern production plants in France, and sales and service offices in Belgium, Germany, the UK, Singapore and Vietnam. The comprehensive product range of Laboratoire AGUETTANT covers four main application areas: emergency medicine, neurology, nutrition and infusion. The Emergency Medicine division offers a wide selection of essential, life-saving drugs, particularly in the areas of catecholamines, anaesthetics and algology, and includes a growing range of sulphite-free products. The Neurology business unit of Laboratoire AGUETTANT is a major player in developing effective treatments for Parkinson’s disease. Laboratoire AGUETTANT specializes in injectable medicines and easyto use delivery systems In particular, it offers injectable solutions to manage motor fluctuations, which affect many patients suffering from the terminal illness. In addition, Laboratoire AGUETTANT has developed specific drugs for the therapy of epilepsy disorders. The third product division comprises injectable trace elements for parenteral nutrition. As these micronutrients should be combined with macronutrients, Laboratoire AGUETTANT also offers a complete range of electrolytes and vitamins. The fourth product line includes infusion solutions for urology, rinsing and care. In all therapeutic areas, Laboratoire AGUETTANT fulfils the most stringent pharmaceutical quality and safety requirements. Simultaneously, the French pharmaceutical group is committed to making the use of its products as easy and convenient as possible, both for healthcare professionals and patients. This is why Laboratoire AGUETTANT has developed an innovative delivery system for its drugs. “Our unique drug delivery system is ready and easy to use and minimizes waste,” explains Chief Executive Officer Eric Rougemond, who has advanced the company’s globalization in the past three years. “Thanks to the combination of the right drug and the right delivery system, we have achieved a leading market position and a sustainable competitive advantage in the international pharmaceutical industry.” The special AGUETTANT drug delivery system is a result of the company’s constant efforts in bringing effective pharmaceuticals and efficient technology together to provide hospital staff and patients with an easy-to-use, safe solution. The Ready-to-use syringes offer the highest standards of safety and hygiene in every situation
EB_ePaper_France_2016
To see the actual publication please follow the link above